Showing results (1611-1620 of 10,872) with videos related to
Sort By:
Pageof 1,088
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 1, 1990
Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjögren's syndromeP M Speight, A Cruchley, D M WilliamsDevelopment and Psychopathology|February 2, 2012
Inner speech is used to mediate short-term memory, but not planning, among intellectually high-functioning adults with autism spectrum disorderDavid M Williams, Dermot M Bowler, Christopher JarroldJournal of Amino Acids|February 15, 2012
Protein modification by dicarbonyl molecular species in neurodegenerative diseasesWesley M Williams, Aaron Weinberg, Mark A SmithJournal of Bacteriology|April 1, 1996
A complex four-gene operon containing essential cell division gene pbpB in Bacillus subtilisR A Daniel, A M Williams, J ErringtonArchives Internationales De Pharmacodynamie Et De Therapie|October 1, 1979
The neuropharmacology of a novel gamma-aminobutyric acid analog, kojic amineG G Yarbrough, M Williams, D R HaubrichJournal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 1, 1989
Epithelial HLA-DR expression in labial salivary glands in Sjögren's syndrome and non-specific sialadenitisP M Speight, A Cruchley, D M WilliamsThe European Journal of Neuroscience|September 3, 2015
Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseasesStephanie M Williams, Philip Schulz, Michael R SierksPharmacology & Therapeutics|December 7, 2018
Cytochrome P450 epoxygenases and cancer: A genetic and a molecular perspectiveLindsay N Sausville, Scott M Williams, Ambra PozziChemistry (Weinheim an Der Bergstrasse, Germany)|March 26, 2018
Gold(III) Complexes for Antitumor Applications: An OverviewBenoît Bertrand, Morwen R M Williams, Manfred BochmannDiabetes, Obesity & Metabolism|September 18, 2020
A look to the future in non-alcoholic fatty liver disease: Are glucagon-like peptide-1 analogues or sodium-glucose co-transporter-2 inhibitors the answer?Rebecca K Vincent, David M Williams, Marc EvansPageof 1,088